Inovio Pharma (INO) – Business Wire
-
QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO’s VGX-3100 for Advanced Cervical Dysplasia
-
Notice of Lead Plaintiff Deadline for Shareholders in the Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit
-
Notice of Lead Plaintiff Deadline for Shareholders in the Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit
-
Notice of Lead Plaintiff Deadline for Shareholders in the Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit
-
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
-
BLS Pharma Alleges Inovio’s Breach of Contract Obstructed Ability to Deliver Testosterone Replacement Therapy for Hypogonadism and the Transgender Community
Back to INO Stock Lookup
